The Johns Hopkins Heartburn Center Registry
NCT03853772 is an observational study sponsored by Johns Hopkins University. As of 21 Nov 2026, it is enrolling by invitation only. It studies Barrett Esophagus, Esophagitis and 2 more conditions. The registry lists an enrollment of 2,000 participants at 9 sites in 1 country. The registry lists a start date of 27 Apr 2019 and a primary completion date of 31 Dec 2027.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT03853772 |
| Status | Enrolling by invitation |
| Study type | Observational study |
| Lead sponsor | Johns Hopkins University |
| Enrollment | 2,000 |
| Registered sites | 9 |
| Countries | 1 |
| Conditions | Barrett Esophagus, Esophagitis, Gastroesophageal Reflux Disease and Laryngopharyngeal Reflux |
| Start | 27 Apr 2019 |
| Primary completion | 31 Dec 2027 |
| Study completion | 31 Dec 2028 |
| Last update posted | 26 Aug 2026 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Marcia Canto, MD
Johns Hopkins University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Uci-Irvine
Orange
- Johns Hopkins Hospital
Baltimore
- Mayo Clinic
Rochester
- Unrmed-University of Nevada, Reno
Reno
- Weill Cornell
New York
- Geisinger
Danville
- the Matagorda Regional Medical Group
Bay City
- Ut Health
Houston
- Fox Valley Surgical Associates
Appleton
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT03853772
Each answer restates registry values shown on this page.
What is NCT03853772?
NCT03853772 is an observational study sponsored by Johns Hopkins University. It studies Barrett Esophagus, Esophagitis and 2 more conditions.
Is NCT03853772 recruiting?
As of 21 Nov 2026, it is enrolling by invitation only.
Who leads NCT03853772?
The registry names Marcia Canto, MD (principal investigator, Johns Hopkins University) as the overall official.
Where does NCT03853772 run?
The registry lists 9 sites in 1 country. Every site with a stated country is in one country: United States.
When is NCT03853772 expected to complete?
The registry lists a primary completion date of 31 Dec 2027 and a study completion date of 31 Dec 2028. The sponsor last updated the record on 26 Aug 2026.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.